Selected catalogue fields; this score does not confirm eligibility or application readiness.Application evidence · 6 of 7 selected topics
Deadline
Official sources conflict — confirm with host
Funding
Published by official source
International eligibility
Published by official source
Registration
Published by official source
Language
Published by official source
Visa / work authorisation
Published by official source
Required documents
Published by official source
Faculty documentation: 7 individual profile sources linked. Photos and roster sources are assessed separately.
The count covers the topics above. Clinical privileges and your own eligibility require separate confirmation with the host.
DECISION SUMMARY
Key facts at a glance
Eligibility
Entry requirements published; check international conditions
Funding / fees
Paid on MD Anderson's GME stipend scale; the fellow's PGY level is not stated on the programme page. Separately, the programme sponsors meeting attendance when the fellow presents MD Anderson data or projects; this is presentation-travel support, not a stated salary amount.Published by official source. Financial support may cover expenses; it does not establish employment or a salary.
Deadline
MD Anderson gives 31 December of the year before the desired start. That guidance does not identify which cutoff applies to the August 2028 positions listed in the 2027 SF Match calendar. Confirm the application deadline with the programme.
Duration
1-year Clinical Fellowship, with an optional second-year Advanced Musculoskeletal Oncology Fellowship (clinical, surgery and research) after completing the clinical year
Hands-on
Unclear — confirm privileges
Clinical exposureThe largest sarcoma centre in the US: two four-month service rotations and four months as a self-directed "super fellow", inpatient and outpatient care with physician assistants and a nurse practitioner, second call from home, acute care centre consultations, and clinical and basic science research with Rice University and UTHealth engineers
Participation levelClinical participation and hands-on restrictions must be confirmed directly with the host.
INTERNATIONAL APPLICANT CHECK
Can an international surgeon apply?
≈Partially published
International applicants
MD Anderson considers graduates of select foreign medical schools and residencies who meet Texas Medical Board licensure requirements and hold a current ECFMG certificate; the J-1 visa sponsored by ECFMG is the required visa for trainees needing sponsorship.
?Confirm directly with host
Clinical role
Clinical or combined training pathway; exact duties remain appointment-specific. Hands-on participation and operative restrictions are not explicitly published.
≈Partially published
Medical registration
Applicants must meet Texas Medical Board requirements for licensure.
✓Published by official source
Language
No English-language test or score is published on the reviewed MD Anderson fellowship details page or GME eligibility requirements page (15 October 2026). The GME eligibility page, which covers all MD Anderson residency and fellowship applicants, states that documents in a language other than English must be accompanied by a certified translation. Confirm any further requirement with the programme coordinator.
≈Partially published
Visa or work authorisation
The J-1 visa, sponsored by ECFMG, is the required visa for international trainees needing visa sponsorship.
DATA QUALITY & AVAILABILITYField-by-field evidence and review datesChecked 2026-11-14 · Next scheduled editorial review: 2027-05-13
✓ programme title✓ institution / department✓ city and country✓ programme classification✓ subspecialty✓ duration✓ positions✓ commencement / intake✓ funding✓ benefits✓ eligibility✓ international eligibility✓ language✓ registration✓ visa / work authorisation✓ application process✓ required documents✓ application portal✓ official contact✓ faculty✓ verified faculty photograph✓ verified institution logo✓ official source✓ institutional source✓ accreditation / organisation source✓ verification date— Current availability unconfirmed · current availability unconfirmed— accommodation / relocation · not published by the cited official source— Current deadline not yet published · official sources conflict
APPLICATION TIMELINE & CONTACT
Plan the application
Application deadlineMD Anderson gives 31 December of the year before the desired start. That guidance does not identify which cutoff applies to the August 2028 positions listed in the 2027 SF Match calendar. Confirm the application deadline with the programme.
Commencing date1 August
Application route / cycle2027 Orthopaedic Fellowship Match (SF Match, MSTS-sponsored) for August 2028 positions: applicant registration opened 3 August 2026 and stays open until the match deadline; CAS target date 2 September 2026 is not a deadline (CAS distributes applications until the day before the rank-list deadline; programmes may set their own deadlines); interview period 17 December 2026 – March 2027; rank lists due 6 April 2027 (12:00 PT); match results 13 April 2027.
Graduates of select foreign medical schools and residencies are considered if they meet Texas Medical Board licensure requirements
Applicants from outside the United States must have a current ECFMG certificate
Meet MD Anderson GME preliminary eligibility requirements
Application documents
Published by official source
Completed application form
Current CV
Letter of good standing
Copies of certificates
Transcript
Three letters of recommendation
PROGRAM OVERVIEW
What this program offers
A two-position musculoskeletal oncology fellowship at MD Anderson, the largest US sarcoma centre, with an optional advanced second year, matched through SF Match with applications due 31 December before an August start; J-1 visas only.
Intended for: Orthopaedic surgeons who have completed an orthopaedic residency
BENEFITS & SUPPORT
Published benefits and support
MD Anderson employee benefits including health insurance, retirement planning, disability insurance and six weeks of parental leave. The programme director's letter additionally offers sponsorship for meetings presenting MD Anderson work, optional AAOS annual-meeting attendance and anticipated participation in the Musculoskeletal Tumor Society meeting. One research project is required for graduation.
HOST INSTITUTION
About The University of Texas MD Anderson Cancer Center Department of Orthopaedic Oncology
MD Anderson's Department of Orthopaedic Oncology began its GME programme in 1999, has trained 45 fellows and has seven subspecialty-trained orthopaedic oncologists.
Program Director; Professor and ChairIndividual profile linkedPhoto source linked
Position / status
Professor and Chair, Department of Orthopaedic Oncology, and Director, Musculoskeletal Oncology Fellowship, MD Anderson Cancer Center
Affiliation
The University of Texas MD Anderson Cancer Center
Clinical focus
Orthopaedic oncology; limb salvage and pelvic sarcoma surgery in adult and paediatric patients
Dr Valerae O. Lewis, MD, is Professor and Chair of the Department of Orthopaedic Oncology at The University of Texas MD Anderson Cancer Center in Houston. Her faculty profile also lists her as Associate Director of the Thoracic/Orthopaedic Center and of the Sarcoma Center, and gives particular expertise in limb salvage and pelvic sarcoma surgery in adult and paediatric patients. It states that she started the Multidisciplinary Pelvic Sarcoma Program at MD Anderson in 2011. Administrative appointments listed include Director of the Musculoskeletal Oncology Fellowship and Residency Coordinator since 2002, and Department Chair since 2015. She is listed as President-Elect of the International Society of Limb Salvage from 2026 and is a past president of the Western Orthopaedic Association. The linked fellowship's intake, supervision and current availability must be confirmed with the host.
Professor, Department of Orthopaedic Oncology, The University of Texas MD Anderson Cancer Center; founding Director, IDEAS Lab
Affiliation
The University of Texas MD Anderson Cancer Center
Clinical focus
Surgical treatment of complex spine and pelvic tumours using 3D computer-assisted technology.
Qualifications
MD, Mount Sinai School of Medicine (2004); orthopaedic surgery residency, Mount Sinai Hospital; fellowships in musculoskeletal oncology (MD Anderson) and orthopaedic spine surgery (UTHealth Houston)
Justin E. Bird, M.D., is a Professor in the Department of Orthopaedic Oncology at The University of Texas MD Anderson Cancer Center in Houston. His faculty profile states that he specialises in the surgical treatment of complex spine and pelvic tumours using 3D computer-assisted technology, and that he is the Division of Surgery Innovation Safety Officer and founding Director of the IDEAS Lab. He received his MD from Mount Sinai School of Medicine in 2004, completed orthopaedic surgery residency at The Mount Sinai Hospital, and held clinical fellowships in musculoskeletal oncology at MD Anderson (2010-2011) and orthopaedic spine surgery at UTHealth Houston (2011-2012). The linked fellowship's intake, supervision and current availability must be confirmed with the host.
Assistant Professor, Orthopaedic Oncology, Department of Orthopaedic Oncology, The University of Texas MD Anderson Cancer Center
Affiliation
The University of Texas MD Anderson Cancer Center
Clinical focus
Musculoskeletal Oncology training and clinical practice
Qualifications
MD, Morehouse School of Medicine (2013); orthopaedic surgery residency, Baylor College of Medicine (2013-2018); Musculoskeletal Oncology Fellowship, MD Anderson (2018-2019); American Board of Orthopaedic Surgery (2021).
Alysia Kemp, MD, is an Assistant Professor in the Department of Orthopaedic Oncology at The University of Texas MD Anderson Cancer Center in Houston. Her faculty profile lists a Doctor of Medicine from Morehouse School of Medicine in 2013, orthopaedic surgery residency at Baylor College of Medicine from 2013 to 2018, and a musculoskeletal oncology fellowship at MD Anderson in 2018 to 2019. The profile lists American Board of Orthopaedic Surgery certification in 2021, a 2024 Texas Medical Board licence, and administrative roles including summer medical student coordinator for orthopaedic oncology and committee service at the institution. Fellowship intake, supervision and current availability must be confirmed with the host.
Professor, Department of Orthopaedic Oncology, The University of Texas MD Anderson Cancer Center
Affiliation
The University of Texas MD Anderson Cancer Center
Clinical focus
Limb salvage and research in sarcomas and tumours of connective tissue; biomechanics of restoring large skeletal defects
Qualifications
MD, Stanford University School of Medicine (1990); orthopaedic residency, University of North Carolina; orthopaedic oncology fellowship, Memorial Sloan-Kettering Cancer Center (1996-1998); American Board of Orthopaedic Surgery
Dr Patrick Lin is Professor in the Department of Orthopaedic Oncology at The University of Texas MD Anderson Cancer Center in Houston. His faculty profile describes a specialism in limb salvage, with research on the biology of tumours involving connective tissue and on the biomechanics of restoring large skeletal defects. He obtained his MD at Stanford University School of Medicine in 1990, completed orthopaedic residency at the University of North Carolina Hospitals and a clinical fellowship in orthopaedic oncology at Memorial Sloan-Kettering Cancer Center. The profile lists him as a member of the Clinical Competency Committee of the Musculoskeletal Oncology Fellowship at MD Anderson (2014 to present). The linked fellowship's intake, supervision and current availability must be confirmed with the host.
Professor and Deputy Chair, Department of Orthopaedic Oncology, MD Anderson Cancer Center
Affiliation
The University of Texas MD Anderson Cancer Center
Clinical focus
Benign and malignant musculoskeletal tumours; metastatic disease and limb-salvage surgery
Qualifications
MD, University of Florida (1995); orthopaedics residency, University of Missouri-Kansas City (2001); orthopaedic oncology fellowship, University of Florida (2002)
Bryan S. Moon is listed as Professor and Deputy Chair in the Department of Orthopaedic Oncology at The University of Texas MD Anderson Cancer Center, Houston. His profile states that he joined the institution in December 2008, treats benign and malignant musculoskeletal tumours, and has particular expertise in metastatic disease and limb-salvage surgery. He is also Quality Officer for the department. Training listed includes an MD from the University of Florida (1995), orthopaedic residency at the University of Missouri-Kansas City (1997-2001) and an orthopaedic oncology fellowship at the University of Florida (2001-2002). He holds American Board of Orthopaedic Surgery certification (2008). The linked fellowship's intake, supervision and current availability must be confirmed with the host.
Assistant Professor, Orthopaedic Oncology; Associate Director of Residency Education, UT MD Anderson Cancer Center
Affiliation
The University of Texas MD Anderson Cancer Center
Clinical focus
Complex sarcomas and tumours of the spine, sacrum and pelvis; spine surgery in cancer patients; bone and soft tissue tumours of the extremities
Qualifications
MD, Harvard-MIT HST (2015); BA, Rice University (2010); orthopaedic residency in Boston (2015-2020); spine surgery fellowship, Washington University (2020-2021); musculoskeletal oncology fellowship, MD Anderson (2021-2022)
Shalin S. Patel, MD, is an Assistant Professor in the Department of Orthopaedic Oncology at The University of Texas MD Anderson Cancer Center in Houston. His faculty profile lists clinical interests in complex sarcomas and tumours of the spine, sacrum and pelvis, spine surgery in patients with cancer, and benign and malignant bone and soft tissue tumours of the extremities. He received his MD from the Harvard-MIT Health Sciences and Technology programme, trained in the Harvard Combined Orthopaedic Residency Program, and completed spine fellowship training at Washington University and a musculoskeletal oncology fellowship at MD Anderson. He directs the Learning Cancer Outcomes Research Program and is Associate Director of Residency Education. Intake, supervision and current availability of the linked fellowship must be confirmed with the host.
MD, Harvard Medical School (1994); PhD, Massachusetts Institute of Technology (1993); orthopaedic residency, UCSF; orthopaedic oncology clinical fellowship, University of Florida; American Board of Orthopaedic Surgery
Robert L. Satcher, MD, PhD, is Professor in the Department of Orthopaedic Oncology at The University of Texas MD Anderson Cancer Center, Houston. His faculty profile lists clinical expertise in skeletal metastatic disease, soft-tissue sarcoma, technology-driven approaches to surgical outcomes, teleoncology and intraoperative navigation, and translational research on treatment resistance in bone metastasis. He holds an MD from Harvard Medical School and a PhD from MIT, completed orthopaedic residency at UCSF and an orthopaedic oncology fellowship at the University of Florida, and is a former NASA astronaut. The intake, supervision and current availability of the linked fellowship must be confirmed with the host.
Names and roles come from the cited programme source; photographs have their own cited source and do not establish an individual profile. Rosters may change.
TERFSES Shoulder and Elbow FellowshipShoulder & Elbow · Texas Education and Research Foundation for Shoulder and Elbow Surgery · Houston, Texas, United States
UTHealth Houston Orthopaedic Trauma FellowshipTrauma, Pelvis & Acetabulum · McGovern Medical School at UTHealth Houston / Memorial Hermann–Texas Medical Center · Houston, Texas, United States
Optional Google Analytics
It stays off unless you allow it, and declining does not limit access. Privacy policy